Inventor · disambiguated record
Timothy Mcafoos
Also filed as: MCAFOOS TIMOTHY · MCAFOOS TIMOTHY J · MCAFOOS TIMOTHY JOSEPH
17 granted patents·9 pending applications·97 citations·filing 2001–2024
92Inventor score
Files withUNIV TEXAS21NAVIRE PHARMA INC2BOARD OF REGENTS UNIV OF TEXAS SYSTEM1CLOSURE MEDICAL CORP1INST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT1
Top patents by PatentIndex Score
26 records- 0196US11370786B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Jun 28, 2022·6 cites·17 claims
- 0295US11958849B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2022·Granted Apr 16, 2024·2 cites·12 claims
- 0395US10954243B2Substituted heterocyclic inhibitors of PTPN11NAVIRE PHARMA INC·Filed 2019·Granted Mar 23, 2021·35 cites·18 claims
- 0494US12186324B2Imidazopiperazine inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2021·Granted Jan 7, 2025·3 cites·26 claims
- 0594US10766892B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2019·Granted Sep 8, 2020·9 cites·26 claims
- 0693US9809588B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Granted Nov 7, 2017·15 cites·27 claims
- 0792US10344025B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2017·Granted Jul 9, 2019·12 cites·11 claims
- 0889US11058688B2Imidazopiperazine inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2019·Granted Jul 13, 2021·3 cites·41 claims
- 0988US9663504B2Salts of heterocyclic modulators of HIF activity for treatment of diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2015·Granted May 30, 2017·6 cites·30 claims
- 1086US2024360121A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2024·Application pending·0 cites
- 1185US10899769B2Imidazopiperazinone inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2019·Granted Jan 26, 2021·3 cites·26 claims
- 1281US10363248B2Salts of heterocyclic modulators of HIF activity for treatment of diseaseUNIV TEXAS·Filed 2017·Granted Jul 30, 2019·2 cites·28 claims
- 1380US2025127792A1Imidazopiperazine inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2024·Application pending·0 cites
- 1477US11028083B2Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferasesUNIV TEXAS·Filed 2019·Granted Jun 8, 2021·1 cites·36 claims
- 1574US10888554B2Salts of heterocyclic modulators of HIF activity for treatment of diseaseUNIV TEXAS·Filed 2019·Granted Jan 12, 2021·0 cites·19 claims
- 1670US2021137910A1Salts of heterocyclic modulators of hif activity for treatment of diseaseUNIV TEXAS·Filed 2020·Application pending·0 cites
- 1765US2025049809A1Inhibitors of mutant idh1 and idh2UNIV TEXAS·Filed 2024·Application pending·0 cites
- 1864US11725008B2Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferasesUNIV TEXAS·Filed 2021·Granted Aug 15, 2023·0 cites·13 claims
- 1964US2023416261A1Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferasesUNIV TEXAS·Filed 2023·Application pending·0 cites
- 2061US11932643B2Substituted heterocyclic inhibitors of PTPN11NAVIRE PHARMA INC·Filed 2021·Granted Mar 19, 2024·0 cites·21 claims
- 2148US11046649B2Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenaseUNIV TEXAS·Filed 2019·Granted Jun 29, 2021·0 cites·23 claims
- 2247US2003082116A1Adhesive compositions containing dual function stabilizers and active agentsCLOSURE MEDICAL CORP·Filed 2001·Application pending·0 cites
- 2345US2014073634A1Heterocyclic modulators of hif activity for treatment of diseaseINST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT·Filed 2013·Application pending·0 cites
- 2442US11173145B2Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenaseUNIV TEXAS·Filed 2018·Granted Nov 16, 2021·0 cites·27 claims
- 2540US2016002204A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
- 2635US2016002248A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →